Currently, plasma cannot be artificially made in a laboratory. Plasma, a component of blood, contains complex proteins and antibodies that are difficult to replicate synthetically. This complexity makes human donation essential for obtaining plasma used in therapies for various conditions, such as immune deficiencies and clotting disorders. Companies like CSL, Takeda, Grifols, Octapharma, Kedrion, etc. rely on plasma donations to produce life-saving treatments. As a result, plasma donation remains a critical process in the global healthcare industry.
top of page
bottom of page
Comments